With regard to the transcriptional activation observed in WM115 cells following cell exposure to MAPK inhibitors, a potential explanation could be the activation of Notch pathway in which factor Notch1 directly regulates the transcription of neuregulin by binding to its promoter region contributing in this way to melanoma tumorigenicity [23,42,43,44]. The gene discussed is NOTCH1; the disease is melanoma.